Artal Group as of Sept. 30, 2017
Portfolio Holdings for Artal Group
Artal Group holds 98 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 42.7 | $2.5B | 88M | 28.35 | |
| Weight Watchers International | 22.1 | $1.3B | 29M | 43.55 | |
| Lexicon Pharmaceuticals (LXRX) | 12.2 | $707M | 58M | 12.29 | |
| Bank of America Corporation (BAC) | 4.3 | $250M | 9.9M | 25.34 | |
| Incyte Corporation (INCY) | 1.1 | $64M | 550k | 116.74 | |
| Goldman Sachs (GS) | 0.8 | $47M | 200k | 237.19 | |
| Nektar Therapeutics | 0.8 | $44M | 1.9M | 24.00 | |
| Bristol Myers Squibb (BMY) | 0.7 | $41M | 650k | 63.74 | |
| Allergan | 0.7 | $41M | 200k | 204.95 | |
| Wells Fargo & Company (WFC) | 0.6 | $36M | 650k | 55.15 | |
| Array BioPharma | 0.5 | $31M | 2.5M | 12.30 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $30M | 450k | 66.75 | |
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $29M | 250k | 117.49 | |
| International Business Machines (IBM) | 0.5 | $29M | 200k | 145.08 | |
| BioMarin Pharmaceutical (BMRN) | 0.5 | $28M | 300k | 93.07 | |
| Acceleron Pharma | 0.5 | $26M | 700k | 37.32 | |
| Amicus Therapeutics (FOLD) | 0.4 | $26M | 1.7M | 15.08 | |
| Bluebird Bio | 0.4 | $25M | 185k | 137.35 | |
| Neurocrine Biosciences (NBIX) | 0.4 | $25M | 400k | 61.28 | |
| American Airls (AAL) | 0.4 | $24M | 500k | 47.49 | |
| Radius Health | 0.4 | $23M | 600k | 38.55 | |
| Beigene (ONC) | 0.4 | $23M | 225k | 103.46 | |
| BlackRock | 0.4 | $22M | 50k | 447.10 | |
| Citigroup (C) | 0.4 | $22M | 300k | 72.74 | |
| MetLife (MET) | 0.4 | $21M | 400k | 51.95 | |
| Gilead Sciences (GILD) | 0.3 | $20M | 250k | 81.02 | |
| Intel Corporation (INTC) | 0.3 | $19M | 500k | 38.08 | |
| Amgen (AMGN) | 0.3 | $19M | 100k | 186.45 | |
| Medicines Company | 0.3 | $19M | 500k | 37.04 | |
| Global Blood Therapeutics In | 0.3 | $17M | 550k | 31.05 | |
| Juno Therapeutics | 0.3 | $16M | 350k | 44.86 | |
| Morgan Stanley (MS) | 0.2 | $15M | 300k | 48.17 | |
| Teradyne (TER) | 0.2 | $13M | 350k | 37.29 | |
| Ironwood Pharmaceuticals (IRWD) | 0.2 | $13M | 817k | 15.77 | |
| Tesaro | 0.2 | $13M | 100k | 129.11 | |
| 58 Com Inc spon adr rep a | 0.2 | $13M | 200k | 63.14 | |
| Horizon Pharma | 0.2 | $13M | 1.0M | 12.68 | |
| Avexis | 0.2 | $12M | 120k | 96.73 | |
| Agenus | 0.2 | $11M | 2.5M | 4.41 | |
| Ignyta | 0.2 | $11M | 900k | 12.35 | |
| Atara Biotherapeutics | 0.2 | $9.9M | 600k | 16.55 | |
| Clovis Oncology | 0.2 | $9.5M | 115k | 82.40 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $9.1M | 200k | 45.36 | |
| Sage Therapeutics (SAGE) | 0.2 | $9.3M | 150k | 62.30 | |
| Seres Therapeutics | 0.1 | $8.8M | 550k | 16.04 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $7.3M | 1.5M | 4.85 | |
| Alder Biopharmaceuticals | 0.1 | $6.1M | 500k | 12.25 | |
| Audentes Therapeutics | 0.1 | $5.6M | 200k | 28.01 | |
| Ac Immune Sa (ACIU) | 0.1 | $5.6M | 500k | 11.17 | |
| Seattle Genetics | 0.1 | $5.4M | 100k | 54.41 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $5.3M | 160k | 32.95 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $5.2M | 150k | 34.95 | |
| Achillion Pharmaceuticals | 0.1 | $4.5M | 1.0M | 4.49 | |
| Accelr8 Technology | 0.1 | $4.5M | 200k | 22.45 | |
| Tg Therapeutics (TGTX) | 0.1 | $4.7M | 400k | 11.85 | |
| Vital Therapies | 0.1 | $4.4M | 875k | 5.05 | |
| Elf Beauty (ELF) | 0.1 | $4.5M | 200k | 22.55 | |
| Achaogen | 0.1 | $4.0M | 250k | 15.95 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $4.1M | 500k | 8.19 | |
| Intellia Therapeutics (NTLA) | 0.1 | $4.3M | 175k | 24.85 | |
| BioCryst Pharmaceuticals (BCRX) | 0.1 | $3.4M | 650k | 5.24 | |
| BioTime | 0.1 | $3.6M | 1.3M | 2.84 | |
| Newlink Genetics Corporation | 0.1 | $3.6M | 350k | 10.18 | |
| Verastem | 0.1 | $3.5M | 750k | 4.70 | |
| Chemocentryx | 0.1 | $3.7M | 500k | 7.42 | |
| Macrogenics (MGNX) | 0.1 | $3.7M | 200k | 18.48 | |
| Zafgen | 0.1 | $3.5M | 1.0M | 3.52 | |
| Dynavax Technologies (DVAX) | 0.1 | $3.2M | 150k | 21.50 | |
| Axovant Sciences | 0.1 | $3.4M | 500k | 6.88 | |
| D Stemline Therapeutics | 0.1 | $2.8M | 250k | 11.10 | |
| Chimerix (CMRX) | 0.1 | $2.6M | 500k | 5.25 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $2.7M | 50k | 53.26 | |
| Glycomimetics | 0.1 | $2.8M | 203k | 13.99 | |
| Calithera Biosciences | 0.1 | $2.8M | 175k | 15.75 | |
| Fibrogen | 0.1 | $2.7M | 50k | 53.80 | |
| Cellectis S A (CLLS) | 0.1 | $2.8M | 100k | 28.45 | |
| Jounce Therapeutics | 0.1 | $3.1M | 200k | 15.58 | |
| Five Prime Therapeutics | 0.0 | $2.0M | 50k | 40.92 | |
| Xencor (XNCR) | 0.0 | $2.3M | 100k | 22.92 | |
| Bellicum Pharma | 0.0 | $2.3M | 200k | 11.55 | |
| Aduro Biotech | 0.0 | $2.1M | 200k | 10.65 | |
| Celldex Therapeutics | 0.0 | $1.9M | 675k | 2.86 | |
| Minerva Neurosciences | 0.0 | $1.9M | 251k | 7.60 | |
| Kura Oncology (KURA) | 0.0 | $1.5M | 100k | 14.95 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $1.8M | 153k | 11.70 | |
| Noveliontherapeuti.. | 0.0 | $1.8M | 256k | 7.03 | |
| Biohaven Pharmaceutical Holding | 0.0 | $1.9M | 50k | 37.38 | |
| Versartis | 0.0 | $980k | 400k | 2.45 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 0.0 | $1.3M | 250k | 5.05 | |
| Corbus Pharmaceuticals Hldgs | 0.0 | $1.1M | 150k | 7.15 | |
| Nantkwest | 0.0 | $1.2M | 225k | 5.48 | |
| Dimension Therapeutics | 0.0 | $1.4M | 235k | 6.00 | |
| Oncocyte | 0.0 | $1.1M | 150k | 7.55 | |
| Miragen Therapeutics | 0.0 | $915k | 100k | 9.15 | |
| Argenx Se (ARGX) | 0.0 | $1.2M | 54k | 22.62 | |
| Krystal Biotech (KRYS) | 0.0 | $997k | 100k | 9.97 | |
| Novavax | 0.0 | $570k | 500k | 1.14 | |
| Xenon Pharmaceuticals (XENE) | 0.0 | $443k | 150k | 2.95 |
